<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-100323" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Stable Angina</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gillen</surname>
            <given-names>Caitlin</given-names>
          </name>
          <aff>University Hospitals</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Goyal</surname>
            <given-names>Amandeep</given-names>
          </name>
          <aff>University of Kansas Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Caitlin Gillen declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Amandeep Goyal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>19</day>
          <month>12</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-100323.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Angina affects 10 million people in the United States. Providers must be able to differentiate between stable angina and other causes of chest pain to care for their patients appropriately. The recognition and appropriate management of stable angina is critical in reducing the risks of future myocardial infarction. This activity highlights an interprofessional team's diagnosis, evaluation, and management of stable angina.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify and appropriately diagnose stable angina.</p></list-item><list-item><p>Determine the&#x000a0;pathophysiology behind myocardial ischemia to assist in treatment options.</p></list-item><list-item><p>Identify and manage risk factors to decrease mortality risk with coronary heart disease.</p></list-item><list-item><p>Communicate&#x000a0;the importance of utilizing an interdisciplinary approach with individuals who have stable angina and multiple comorbidities in order to optimize outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=100323&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=100323">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-100323.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Stable angina, also known as typical angina or angina pectoris, is a symptom of myocardial ischemia. Stable angina is characterized by chest discomfort or anginal equivalent that is provoked with exertion and alleviated at rest or with nitroglycerin. This is often&#x000a0;1 of the first manifestations or warning signs of underlying coronary disease. Angina affects 10 million people in the United States (US); given this, it is important to recognize the signs and symptoms and appropriately risk stratify and manage these individuals.<xref ref-type="bibr" rid="article-100323.r1">[1]</xref></p>
      </sec>
      <sec id="article-100323.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The mechanism behind stable angina is the result of a supply-demand mismatch. The myocardial oxygen demand transiently exceeds the myocardial oxygen supply, often leading to symptoms. Several factors contribute to stable angina; the most common etiology is coronary artery stenosis. This is further discussed below in the section titled &#x02018;Pathophysiology.&#x02019;<xref ref-type="bibr" rid="article-100323.r2">[2]</xref></p>
      </sec>
      <sec id="article-100323.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Coronary&#x000a0;heart disease impacts over 17 million&#x000a0;adults&#x000a0;in the United States. Of the&#x000a0;17 million Americans affected, 55% of those are male. It contributes to over 500,000 deaths each year in the US. At age 40 years, the lifetime risk of developing coronary disease is estimated at 49% for men and 32% for women. The&#x000a0;incidence&#x000a0;of coronary events&#x000a0;increases&#x000a0;with age, although the male predominance of these events gradually narrows with advancing age.<xref ref-type="bibr" rid="article-100323.r3">[3]</xref>&#x000a0;Coronary&#x000a0;heart&#x000a0;disease/ischemic heart disease is not unique to the US; it is the leading cause of death in adults from low, middle, and high-income countries.<xref ref-type="bibr" rid="article-100323.r4">[4]</xref></p>
        <p>Coronary&#x000a0;heart disease can also cause significant debility. This debility can manifest in several ways,&#x000a0;1 of which is angina. Angina affects over 10 million people in the US, with over 500,000 new cases diagnosed each year.<xref ref-type="bibr" rid="article-100323.r1">[1]</xref><xref ref-type="bibr" rid="article-100323.r3">[3]</xref></p>
      </sec>
      <sec id="article-100323.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Simply put, angina results from an imbalance between the myocardial oxygen supply and the myocardial oxygen demand. Understanding the factors that contribute to each of these measures is important.</p>
        <p>Endothelial cells line the coronary arteries, regulate vascular tone, and prevent intravascular thrombosis. Any disruption in these&#x000a0;2 functions can lead to coronary&#x000a0;heart disease. Multiple mechanisms can result in injury or impairment of the endothelial lining. These mechanisms include, but are not limited to, stress, hypertension, hypercholesterolemia, viruses, bacteria, and immune complexes. Endothelial injury triggers an immune response, leading to fibrous tissue formation. Smooth muscle remodeling/fibrous caps can lead to coronary artery stenosis or even acute coronary syndrome.&#x000a0;</p>
        <p>Coronary artery stenosis is the most common cause of myocardial ischemia. During increased myocardial oxygen demand, the stenosis prevents adequate myocardial oxygen supply. Four main factors contribute to oxygen demand: heart rate, systolic blood pressure, myocardial wall tension, and myocardial contractility. In states of increased demand such as illness, stress, and exercise &#x02013; we rely on the body&#x02019;s ability to up-regulate myocardial oxygen supply appropriately.&#x000a0;</p>
        <p>The&#x000a0;4 main factors contributing to myocardial oxygen supply are coronary artery diameter and tone, collateral blood flow, perfusion pressure, and heart rate. While coronary artery stenosis is the most common, other conditions can lead to a decreased myocardial oxygen supply. These examples include but are not limited to, coronary artery vasospasm, embolism, dissection, and micro-vascular disease.<xref ref-type="bibr" rid="article-100323.r2">[2]</xref><xref ref-type="bibr" rid="article-100323.r5">[5]</xref><xref ref-type="bibr" rid="article-100323.r6">[6]</xref></p>
        <p>When the myocardial oxygen demand exceeds the myocardial oxygen supply, this often manifests with symptoms. Myocardial ischemia stimulates chemosensitive and mechanoreceptive receptors within the cardiac muscle fibers and surrounding the coronary vessels.&#x000a0;The activation of these receptors triggers impulses through the sympathetic afferent pathways from the heart to the cervical and thoracic spine. Each spinal level has a corresponding dermatome; the discomfort described by the patient often follows the specific dermatomal pattern.<xref ref-type="bibr" rid="article-100323.r7">[7]</xref><xref ref-type="bibr" rid="article-100323.r8">[8]</xref>&#x000a0;It is important to conduct a thorough workup and evaluation to determine the cause of angina in each individual; understanding the etiology allows for medical optimization and appropriate management of risk factors.</p>
      </sec>
      <sec id="article-100323.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Individuals with stable angina often have a subacute versus chronic presentation. It is important to use history and physical as a screening tool to identify high-risk individuals. Routine screening of blood pressure, weight, sleep habits, stress, exercise tolerance, tobacco, alcohol, and illicit drug use should be incorporated.</p>
        <p>As previously mentioned, typical angina usually presents as chest discomfort or an anginal equivalent provoked by exertion and alleviated at rest or with nitroglycerin. Anginal equivalents vary, but they are commonly described as shortness of breath, nausea, or fatigue disproportionate to the activity level.&#x000a0;</p>
        <p>It is important to distinguish between cardiac and non-cardiac chest discomfort. Discussing the details of the patient&#x02019;s symptoms further guide this differentiation. Relevant details include the pain's quality, location, influencing factors, timing, and duration.<xref ref-type="bibr" rid="article-100323.r9">[9]</xref></p>
        <p>Typical angina is often described as pressure-like, heaviness, tightness, or squeezing. It most commonly affects a broad area of the chest rather than a specific spot. There may be radiation of the pain, depending on which dermatomes are affected.<xref ref-type="bibr" rid="article-100323.r10">[10]</xref><xref ref-type="bibr" rid="article-100323.r11">[11]</xref>&#x000a0;Symptoms&#x000a0;are described as more severe with increased demand (ie, walking, lifting, emotional stress, etc). Symptoms generally last 2 to&#x000a0;5 minutes, and relief is experienced when the provoking activity is stopped or the patient takes nitroglycerin.<xref ref-type="bibr" rid="article-100323.r9">[9]</xref>&#x000a0;The physical exam is most commonly unremarkable. In the setting of typical angina, you would not expect active ischemia,&#x000a0;leading to nonspecific physical exam findings.&#x000a0;</p>
      </sec>
      <sec id="article-100323.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The evaluation of stable&#x000a0;angina includes:</p>
        <list list-type="bullet">
          <list-item>
            <p>Obtain an electrocardiogram to evaluate for active ischemia or evidence of previous infarction.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Obtain a chest x-ray to assist in ruling out noncardiac explanations for chest pain (ie, infection, trauma, pneumothorax, etc)</p>
          </list-item>
          <list-item>
            <p>Obtain&#x000a0;a complete blood count, comprehensive metabolic panel, lipid panel, and troponin. Lab work&#x000a0;is important in risk stratification and ruling out noncardiac explanations (ie, anemia, infection, renal disease, etc)</p>
          </list-item>
          <list-item>
            <p>Use previous work up to risk stratify, consider stress testing versus further coronary evaluation in moderate to high-risk individuals.&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-100323.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment for stable angina is geared toward reducing risk factors for presumed underlying coronary heart disease.&#x000a0;An interdisciplinary approach&#x000a0;would likely benefit&#x000a0;individuals&#x000a0;with multiple comorbidities: nutrition, diabetic educator, addiction counselor, and physical and occupational therapy.&#x000a0;</p>
        <p>
<bold>First-line Treatment Includes Lifestyle Modifications</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Tobacco cessation results in the biggest risk reduction.&#x000a0;
<list list-type="bullet"><list-item><p>Cigarette smoking is the leading avoidable cause of premature death. The risk of cardiovascular mortality in current smokers is roughly&#x000a0;2 times that of nonsmokers. Interestingly enough, the risk of cardiovascular mortality in former smokers is roughly equal to that&#x000a0;of&#x000a0;individuals who have never smoked. That said, it is imperative to continuously encourage smoking cessation regardless of age or duration of smoking history<xref ref-type="bibr" rid="article-100323.r12">[12]</xref></p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Cholesterol reduction
<list list-type="bullet"><list-item><p>Evidence has supported that adherence to the Mediterranean diet (high in vegetables and fruits) reduces the risk of cardiovascular disease.<xref ref-type="bibr" rid="article-100323.r13">[13]</xref></p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Blood pressure control
<list list-type="bullet"><list-item><p>The 2017 AHA/ACC guidelines define hypertension as systolic blood pressure&#x000a0;&#x02265;130 mmHg or diastolic pressure &#x02265;80 mmHg.<xref ref-type="bibr" rid="article-100323.r14">[14]</xref>&#x000a0;Goal blood pressure&#x000a0;is unique to each patient; however, it is important to remember that for each 20/10 mmHg increase in systolic/diastolic blood pressure, evidence has supported a 2-fold increased risk of coronary heart and stroke-related mortality.<xref ref-type="bibr" rid="article-100323.r15">[15]</xref></p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Diabetes mellitus management
<list list-type="bullet"><list-item><p>Weight reduction, increased physical activity, and adequate control of comorbidities are recommended.<xref ref-type="bibr" rid="article-100323.r16">[16]</xref></p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Weight loss
<list list-type="bullet"><list-item><p>Obesity is the second leading modifiable cause of premature death.<xref ref-type="bibr" rid="article-100323.r17">[17]</xref>&#x000a0;Weight-loss regimens should be catered to each patient, and the discussion should include lifestyle modifications and surgical options if appropriate.&#x000a0;</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Aerobic exercise
<list list-type="bullet"><list-item><p>An average of 150 minutes of moderate-intensity&#x000a0;exercise per week or 75 minutes of high-intensity exercise per week has been shown to decrease overall cardiac risk factors and, in turn, the risk of coronary heart disease.<xref ref-type="bibr" rid="article-100323.r18">[18]</xref></p></list-item></list>
</p>
          </list-item>
        </list>
        <p>Pharmacologic</p>
        <list list-type="bullet">
          <list-item>
            <p>Aspirin: Determine the risk of coronary heart disease in each patient. In low-risk individuals, the use of aspirin for primary prevention decreases the risk of nonfatal MI without benefit in all-cause mortality and nonfatal stroke.<xref ref-type="bibr" rid="article-100323.r19">[19]</xref>&#x000a0;Risk stratification is important as the use of aspirin comes with an increased risk of major bleeding.<xref ref-type="bibr" rid="article-100323.r20">[20]</xref>&#x000a0;Extracranial bleeding is the most common, however daily low-dose aspirin does increase the risk of intracranial hemorrhage as well.<xref ref-type="bibr" rid="article-100323.r21">[21]</xref>&#x000a0;As there is no evidence to support a mortality benefit for the use of aspirin in low-risk individuals, the risk of bleeding may outweigh the anticipated benefit. This should be decided on a case-by-case basis. High-risk individuals or individuals with known cardiovascular disease benefit from&#x000a0;low-dose daily aspirin. According to the meta-analysis performed by the Antithrombotic Trialists' Collaboration, daily aspirin significantly reduced the risk of nonfatal MI, nonfatal stroke, and vascular death by 22%.<xref ref-type="bibr" rid="article-100323.r22">[22]</xref></p>
          </list-item>
          <list-item>
            <p>HMG-CoA reductase inhibitor: Statin therapy in high, moderate, and low-risk primary prevention subjects without clinical evidence of coronary disease has demonstrated a reduction in myocardial infarction, stroke, cardiovascular death, and total mortality.<xref ref-type="bibr" rid="article-100323.r23">[23]</xref></p>
          </list-item>
          <list-item>
            <p>ACE-inhibitor/angiotensin receptor blocker (ARB): It may be used in primary prevention to assist in blood pressure control and is recommended in the setting of high-risk individuals or known cardiovascular disease for cardioprotective efforts. The use of ACE inhibitors or ARBs in high-risk individuals has been shown to reduce the risk of cardiovascular and all-cause mortality.<xref ref-type="bibr" rid="article-100323.r24">[24]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Symptom Control
<list list-type="bullet"><list-item><p>Beta-blockers: Beta-blockers&#x000a0;have been shown to decrease heart rate, blood pressure, and contractility, leading to decreased myocardial oxygen demand and decreased anginal&#x000a0;symptoms.<xref ref-type="bibr" rid="article-100323.r25">[25]</xref></p></list-item><list-item><p>Nitrates: Nitrates relax vascular smooth muscle, leading to dilation of veins primarily; this decreases cardiac preload and, in turn, decreases myocardial oxygen demand, relieving anginal symptoms.<xref ref-type="bibr" rid="article-100323.r26">[26]</xref></p></list-item><list-item><p>Ranolazine: The mechanism of action of this medication is not entirely understood; however, it is FDA-approved for symptom control in stable angina.<xref ref-type="bibr" rid="article-100323.r27">[27]</xref>&#x000a0;&#x000a0;</p></list-item></list>
</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-100323.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Below are several important differential diagnoses to consider (see&#x000a0;<bold>Image.</bold>&#x000a0;Types of Angina in the Coronary Artery). Brief details are listed next to each diagnosis to help differentiate from stable angina. Please reference their designated topics for specific details and diagnostic criteria for each differential diagnosis.</p>
        <p>
<bold>Cardiovascular</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Acute coronary syndrome</p>
          </list-item>
          <list-item>
            <list list-type="bullet">
              <list-item>
                <p>Unstable angina: Detailed history is pertinent.&#x000a0;Chest pain is less likely to follow a predictable pattern, and the patient may even experience chest pain at rest.</p>
              </list-item>
              <list-item>
                <p>NSTEMI: Elevated cardiac enzymes with or without EKG changes.</p>
              </list-item>
              <list-item>
                <p>STEMI: Elevated cardiac enzymes with regional&#x000a0;ST elevations were noted on the EKG.</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>Myocarditis:&#x000a0;Elevated cardiac enzymes with EKG changes.</p>
          </list-item>
          <list-item>
            <p>Pericarditis: Diffuse ST elevations noted on EKG with or without an elevation in cardiac enzymes. Chest pain is pleuritic and&#x000a0;is often relieved by leaning forward.&#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>Gastrointestinal</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Esophageal spasm:&#x000a0;Temporal relationship to meals with or without dysphagia</p>
          </list-item>
          <list-item>
            <p>Gastroesophageal reflux disease:&#x000a0;Temporal relationship to meals</p>
          </list-item>
        </list>
        <p>
<bold>Pulmonary&#x000a0;</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Asthma: Abnormal lung sounds are expected on the exam. Anticipate improvement in symptoms with pulmonary hygiene and inhaled beta-agonists.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Chronic obstructive pulmonary disease:&#x000a0;Abnormal lung sounds are expected on the exam. Anticipate improvement in symptoms with pulmonary hygiene and inhaled beta-agonists.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Pulmonary embolus: Chest pain pleuritic in nature. Typically, the presentation includes tachycardia and hypoxemia.</p>
          </list-item>
        </list>
        <p><bold>Musculoskeletal</bold>&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Costochondritis: Chest pain reproducible on the exam. History often reveals recent heavy lifting or exercise.</p>
          </list-item>
          <list-item>
            <p>Trauma: History reveals the mechanism of trauma. Imaging may reveal fractures.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-100323.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis varies depending on the etiology of stable angina. Regardless of the etiology, aggressive risk factor modification is imperative. In&#x000a0;individuals with stable angina, screening for increased frequency of symptoms or transition to unstable angina should be routinely performed.&#x000a0;</p>
      </sec>
      <sec id="article-100323.s11" sec-type="Complications">
        <title>Complications</title>
        <p>The most important complication of stable angina is&#x000a0;the possibility of&#x000a0;progression to acute coronary syndrome. Risk factor modification and medical optimization should be utilized to decrease risk. These individuals require routine monitoring and attentive primary care providers.</p>
      </sec>
      <sec id="article-100323.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Coronary heart disease is the leading cause of death in the United States, and efforts to educate the public regarding signs and symptoms of myocardial infarction, unstable angina, and stable angina should be continued. Efforts to educate the public regarding preventative measures such as risk factor modification and lifestyle modifications should also be a priority.&#x000a0;</p>
      </sec>
      <sec id="article-100323.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Typical angina affects over 10 million people in the United States. The presentation can vary from chest pressure to fatigue, shortness of breath, and nausea. If this ultimately leads to myocardial infarction or unstable angina, the cardiology team is imperative in treatment; however, there are often many providers that see this individual before that evolution. It is important to utilize an interprofessional team to suit each patient best. The primary care provider plays a large role in primary and secondary prevention, likely for many years before the development of symptoms. This provider may also recruit the help of a nutritionist, diabetic educator, addiction counselor, and physical and occupational therapist to help modify risk factors. The use of an interdisciplinary team is recommended to optimize patient outcomes.</p>
      </sec>
      <sec id="article-100323.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=100323&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=100323">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/heart-health/stable-angina/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=100323">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/100323/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=100323">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-100323.s15">
        <fig id="article-100323.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Types of Angina in the Coronary Artery. The illustration depicts stable angina, unstable angina, and variant angina. Contributed by C Rowe</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Angina" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-100323.s16">
        <title>References</title>
        <ref id="article-100323.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kloner</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Chaitman</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Angina and Its Management.</article-title>
            <source>J Cardiovasc Pharmacol Ther</source>
            <year>2017</year>
            <month>May</month>
            <volume>22</volume>
            <issue>3</issue>
            <fpage>199</fpage>
            <page-range>199-209</page-range>
            <pub-id pub-id-type="pmid">28196437</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100323.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ib&#x000e1;&#x000f1;ez</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Heusch</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ovize</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Van de Werf</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Evolving therapies for myocardial ischemia/reperfusion injury.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2015</year>
            <month>Apr</month>
            <day>14</day>
            <volume>65</volume>
            <issue>14</issue>
            <fpage>1454</fpage>
            <page-range>1454-71</page-range>
            <pub-id pub-id-type="pmid">25857912</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100323.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Benjamin</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Virani</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Callaway</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Chamberlain</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chiuve</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Cushman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Delling</surname>
                <given-names>FN</given-names>
              </name>
              <name>
                <surname>Deo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>de Ferranti</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Ferguson</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Fornage</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gillespie</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Isasi</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Jim&#x000e9;nez</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Jordan</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Judd</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Lackland</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lichtman</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Lisabeth</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Longenecker</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Lutsey</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Mackey</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Matchar</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Matsushita</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mussolino</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Nasir</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>O'Flaherty</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Palaniappan</surname>
                <given-names>LP</given-names>
              </name>
              <name>
                <surname>Pandey</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pandey</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Reeves</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Ritchey</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Rodriguez</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Roth</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Rosamond</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Sampson</surname>
                <given-names>UKA</given-names>
              </name>
              <name>
                <surname>Satou</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Spartano</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Tirschwell</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Tsao</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Voeks</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Willey</surname>
                <given-names>JZ</given-names>
              </name>
              <name>
                <surname>Wilkins</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Alger</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Muntner</surname>
                <given-names>P</given-names>
              </name>
              <collab>American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee</collab>
            </person-group>
            <article-title>Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association.</article-title>
            <source>Circulation</source>
            <year>2018</year>
            <month>Mar</month>
            <day>20</day>
            <volume>137</volume>
            <issue>12</issue>
            <fpage>e67</fpage>
            <page-range>e67-e492</page-range>
            <pub-id pub-id-type="pmid">29386200</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100323.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lopez</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Mathers</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Ezzati</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jamison</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data.</article-title>
            <source>Lancet</source>
            <year>2006</year>
            <month>May</month>
            <day>27</day>
            <volume>367</volume>
            <issue>9524</issue>
            <fpage>1747</fpage>
            <page-range>1747-57</page-range>
            <pub-id pub-id-type="pmid">16731270</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100323.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ganz</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Abben</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Barry</surname>
                <given-names>WH</given-names>
              </name>
            </person-group>
            <article-title>Dynamic variations in resistance of coronary arterial narrowings in angina pectoris at rest.</article-title>
            <source>Am J Cardiol</source>
            <year>1987</year>
            <month>Jan</month>
            <day>01</day>
            <volume>59</volume>
            <issue>1</issue>
            <fpage>66</fpage>
            <page-range>66-70</page-range>
            <pub-id pub-id-type="pmid">3101476</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100323.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hillis</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Braunwald</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Coronary-artery spasm.</article-title>
            <source>N Engl J Med</source>
            <year>1978</year>
            <month>Sep</month>
            <day>28</day>
            <volume>299</volume>
            <issue>13</issue>
            <fpage>695</fpage>
            <page-range>695-702</page-range>
            <pub-id pub-id-type="pmid">210380</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100323.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Foreman</surname>
                <given-names>RD</given-names>
              </name>
            </person-group>
            <article-title>Mechanisms of cardiac pain.</article-title>
            <source>Annu Rev Physiol</source>
            <year>1999</year>
            <volume>61</volume>
            <fpage>143</fpage>
            <page-range>143-67</page-range>
            <pub-id pub-id-type="pmid">10099685</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100323.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Crea</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Gaspardone</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kaski</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Davies</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Maseri</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Relation between stimulation site of cardiac afferent nerves by adenosine and distribution of cardiac pain: results of a study in patients with stable angina.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>1992</year>
            <month>Dec</month>
            <volume>20</volume>
            <issue>7</issue>
            <fpage>1498</fpage>
            <page-range>1498-502</page-range>
            <pub-id pub-id-type="pmid">1452922</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100323.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kreiner</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Okeson</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Michelis</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Lujambio</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Isberg</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Craniofacial pain as the sole symptom of cardiac ischemia: a prospective multicenter study.</article-title>
            <source>J Am Dent Assoc</source>
            <year>2007</year>
            <month>Jan</month>
            <volume>138</volume>
            <issue>1</issue>
            <fpage>74</fpage>
            <page-range>74-9</page-range>
            <pub-id pub-id-type="pmid">17197405</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100323.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Constant</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>The clinical diagnosis of nonanginal chest pain: the differentiation of angina from nonanginal chest pain by history.</article-title>
            <source>Clin Cardiol</source>
            <year>1983</year>
            <month>Jan</month>
            <volume>6</volume>
            <issue>1</issue>
            <fpage>11</fpage>
            <page-range>11-6</page-range>
            <pub-id pub-id-type="pmid">6831781</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100323.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Christie</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Conti</surname>
                <given-names>CR</given-names>
              </name>
            </person-group>
            <article-title>Systematic approach to evaluation of angina-like chest pain: pathophysiology and clinical testing with emphasis on objective documentation of myocardial ischemia.</article-title>
            <source>Am Heart J</source>
            <year>1981</year>
            <month>Nov</month>
            <volume>102</volume>
            <issue>5</issue>
            <fpage>897</fpage>
            <page-range>897-912</page-range>
            <pub-id pub-id-type="pmid">7304398</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100323.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>LaCroix</surname>
                <given-names>AZ</given-names>
              </name>
              <name>
                <surname>Lang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Scherr</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Cornoni-Huntley</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Berkman</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Curb</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Evans</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hennekens</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <article-title>Smoking and mortality among older men and women in three communities.</article-title>
            <source>N Engl J Med</source>
            <year>1991</year>
            <month>Jun</month>
            <day>06</day>
            <volume>324</volume>
            <issue>23</issue>
            <fpage>1619</fpage>
            <page-range>1619-25</page-range>
            <pub-id pub-id-type="pmid">2030718</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100323.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sotos-Prieto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bhupathiraju</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Mattei</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fung</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Pan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Willett</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Rimm</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>FB</given-names>
              </name>
            </person-group>
            <article-title>Changes in Diet Quality Scores and Risk of Cardiovascular Disease Among US Men and Women.</article-title>
            <source>Circulation</source>
            <year>2015</year>
            <month>Dec</month>
            <day>08</day>
            <volume>132</volume>
            <issue>23</issue>
            <fpage>2212</fpage>
            <page-range>2212-9</page-range>
            <pub-id pub-id-type="pmid">26644246</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100323.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Whelton</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Carey</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Aronow</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Casey</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Collins</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Dennison Himmelfarb</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>DePalma</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Gidding</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jamerson</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>MacLaughlin</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Muntner</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ovbiagele</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Spencer</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Stafford</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Taler</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Williamson</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Wright</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.</article-title>
            <source>Hypertension</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>71</volume>
            <issue>6</issue>
            <fpage>e13</fpage>
            <page-range>e13-e115</page-range>
            <pub-id pub-id-type="pmid">29133356</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100323.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>Blood Pressure Lowering Treatment Trialists' Collaboration</collab>
              <name>
                <surname>Ninomiya</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Perkovic</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Turnbull</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Neal</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Barzi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Cass</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Baigent</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chalmers</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Woodward</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>MacMahon</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials.</article-title>
            <source>BMJ</source>
            <year>2013</year>
            <month>Oct</month>
            <day>03</day>
            <volume>347</volume>
            <fpage>f5680</fpage>
            <pub-id pub-id-type="pmid">24092942</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100323.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hennekens</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Pfeffer</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Newcomer</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Jellinger</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Garber</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Treatment of diabetes mellitus: the urgent need for multifactorial interventions.</article-title>
            <source>Am J Manag Care</source>
            <year>2014</year>
            <month>May</month>
            <volume>20</volume>
            <issue>5</issue>
            <fpage>357</fpage>
            <page-range>357-9</page-range>
            <pub-id pub-id-type="pmid">25181565</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100323.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hennekens</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Andreotti</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Leading avoidable cause of premature deaths worldwide: case for obesity.</article-title>
            <source>Am J Med</source>
            <year>2013</year>
            <month>Feb</month>
            <volume>126</volume>
            <issue>2</issue>
            <fpage>97</fpage>
            <page-range>97-8</page-range>
            <pub-id pub-id-type="pmid">23331433</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100323.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Manson</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>FB</given-names>
              </name>
              <name>
                <surname>Rich-Edwards</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Colditz</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Stampfer</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Willett</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Speizer</surname>
                <given-names>FE</given-names>
              </name>
              <name>
                <surname>Hennekens</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <article-title>A prospective study of walking as compared with vigorous exercise in the prevention of coronary heart disease in women.</article-title>
            <source>N Engl J Med</source>
            <year>1999</year>
            <month>Aug</month>
            <day>26</day>
            <volume>341</volume>
            <issue>9</issue>
            <fpage>650</fpage>
            <page-range>650-8</page-range>
            <pub-id pub-id-type="pmid">10460816</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100323.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guirguis-Blake</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Evans</surname>
                <given-names>CV</given-names>
              </name>
              <name>
                <surname>Senger</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>O'Connor</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Whitlock</surname>
                <given-names>EP</given-names>
              </name>
            </person-group>
            <article-title>Aspirin for the Primary Prevention of Cardiovascular Events: A Systematic Evidence Review for the U.S. Preventive Services Task Force.</article-title>
            <source>Ann Intern Med</source>
            <year>2016</year>
            <month>Jun</month>
            <day>21</day>
            <volume>164</volume>
            <issue>12</issue>
            <fpage>804</fpage>
            <page-range>804-13</page-range>
            <pub-id pub-id-type="pmid">27064410</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100323.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>Antithrombotic Trialists' (ATT) Collaboration</collab>
              <name>
                <surname>Baigent</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Blackwell</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Collins</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Emberson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Godwin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Peto</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Buring</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hennekens</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kearney</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Meade</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Patrono</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Roncaglioni</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Zanchetti</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.</article-title>
            <source>Lancet</source>
            <year>2009</year>
            <month>May</month>
            <day>30</day>
            <volume>373</volume>
            <issue>9678</issue>
            <fpage>1849</fpage>
            <page-range>1849-60</page-range>
            <pub-id pub-id-type="pmid">19482214</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100323.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huang</surname>
                <given-names>WY</given-names>
              </name>
              <name>
                <surname>Saver</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>YL</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ovbiagele</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Frequency of Intracranial Hemorrhage With Low-Dose Aspirin in Individuals Without Symptomatic Cardiovascular Disease: A Systematic Review and Meta-analysis.</article-title>
            <source>JAMA Neurol</source>
            <year>2019</year>
            <month>Aug</month>
            <day>01</day>
            <volume>76</volume>
            <issue>8</issue>
            <fpage>906</fpage>
            <page-range>906-914</page-range>
            <pub-id pub-id-type="pmid">31081871</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100323.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <collab>Antithrombotic Trialists' Collaboration</collab>
            <article-title>Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.</article-title>
            <source>BMJ</source>
            <year>2002</year>
            <month>Jan</month>
            <day>12</day>
            <volume>324</volume>
            <issue>7329</issue>
            <fpage>71</fpage>
            <page-range>71-86</page-range>
            <pub-id pub-id-type="pmid">11786451</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100323.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Collins</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Reith</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Emberson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Armitage</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Baigent</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Blackwell</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Blumenthal</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Danesh</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>DeMets</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Evans</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Law</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>MacMahon</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Neal</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Poulter</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Preiss</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ridker</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Rodgers</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sandercock</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Schulz</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sever</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Simes</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Smeeth</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wald</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Yusuf</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Peto</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Interpretation of the evidence for the efficacy and safety of statin therapy.</article-title>
            <source>Lancet</source>
            <year>2016</year>
            <month>Nov</month>
            <day>19</day>
            <volume>388</volume>
            <issue>10059</issue>
            <fpage>2532</fpage>
            <page-range>2532-2561</page-range>
            <pub-id pub-id-type="pmid">27616593</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100323.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bangalore</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fakheri</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wandel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Toklu</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Wandel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Messerli</surname>
                <given-names>FH</given-names>
              </name>
            </person-group>
            <article-title>Renin angiotensin system inhibitors for patients with stable coronary artery disease without heart failure: systematic review and meta-analysis of randomized trials.</article-title>
            <source>BMJ</source>
            <year>2017</year>
            <month>Jan</month>
            <day>19</day>
            <volume>356</volume>
            <fpage>j4</fpage>
            <pub-id pub-id-type="pmid">28104622</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100323.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hauf-Zachariou</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Blackwood</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Gunawardena</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>O'Donnell</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Garnham</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pfarr</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Carvedilol versus verapamil in chronic stable angina: a multicentre trial.</article-title>
            <source>Eur J Clin Pharmacol</source>
            <year>1997</year>
            <volume>52</volume>
            <issue>2</issue>
            <fpage>95</fpage>
            <page-range>95-100</page-range>
            <pub-id pub-id-type="pmid">9174677</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100323.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abrams</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Hemodynamic effects of nitroglycerin and long-acting nitrates.</article-title>
            <source>Am Heart J</source>
            <year>1985</year>
            <month>Jul</month>
            <volume>110</volume>
            <issue>1 Pt 2</issue>
            <fpage>216</fpage>
            <page-range>216-24</page-range>
            <pub-id pub-id-type="pmid">3925741</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100323.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chaitman</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Pepine</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Parker</surname>
                <given-names>JO</given-names>
              </name>
              <name>
                <surname>Skopal</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chumakova</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kuch</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Skettino</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Wolff</surname>
                <given-names>AA</given-names>
              </name>
              <collab>Combination Assessment of Ranolazine In Stable Angina (CARISA) Investigators</collab>
            </person-group>
            <article-title>Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.</article-title>
            <source>JAMA</source>
            <year>2004</year>
            <month>Jan</month>
            <day>21</day>
            <volume>291</volume>
            <issue>3</issue>
            <fpage>309</fpage>
            <page-range>309-16</page-range>
            <pub-id pub-id-type="pmid">14734593</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
